Merck Forward P/E

The Forward P/E of Merck & Co Inc (MRK) is 8.87.

Forward P/E estimates how much investors are willing to pay today for each dollar of a company's expected future earnings. It serves as a valuation tool based on projected profitability rather than past performance.

Merck Forward P/E - Peers Comparison

Ticker	Name	Value
ENDP	Endo International PLC	0.12
JNJ	Johnson & Johnson	14.54
PAHC	Phibro Animal Health Corp	14.26
GTII.CN	Green Thumb Industries Inc	24.24
VTRS	Viatris Inc	4.10
AMRX	Amneal Pharmaceuticals Inc	11.45
INVA	Innoviva Inc	27.62
MNKKQ	Mallinckrodt PLC	0.00
BHC.TO	Bausch Health Companies Inc	1.53
CORT	Corcept Therapeutics Inc	48.04
PCRX	Pacira Biosciences Inc	8.25
SUPN	Supernus Pharmaceuticals Inc	18.54
BMY	Bristol-Myers Squibb Co	6.89
CTLT	Catalent Inc	55.81
HZNP	Horizon Therapeutics PLC	25.39
JAZZ	Jazz Pharmaceuticals PLC	21.44
LLY	Eli Lilly and Co	35.36
ZTS	Zoetis Inc	24.59
PFE	Pfizer Inc	8.27